The view from Deloitte

By developing strategies to address these seven key insights, life sciences companies should be able to transform compliance activity from a cost to something that delivers value and sustainable competitive advantage for the organization.

Overall, even though the compliance challenges facing the industry are numerous, the timing could not be better for compliance functions to transform themselves from tactical enforcer to strategic advisor.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see www.deloitte.com/about to learn more about our global network of member firms.